CytomX Therapeutics Return on Investment 2014-2022 | CTMX
Current and historical return on investment (ROI) values for CytomX Therapeutics (CTMX) over the last 10 years.
| CytomX Therapeutics ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2022-09-30 |
$-0.10B |
|
inf% |
| 2022-06-30 |
$-0.10B |
|
inf% |
| 2022-03-31 |
$-0.09B |
|
inf% |
| 2021-12-31 |
$-0.08B |
|
inf% |
| 2021-09-30 |
$-0.07B |
|
inf% |
| 2021-06-30 |
$-0.07B |
|
inf% |
| 2021-03-31 |
$-0.06B |
|
inf% |
| 2020-12-31 |
$-0.05B |
|
inf% |
| 2020-09-30 |
$-0.07B |
|
inf% |
| 2020-06-30 |
$-0.08B |
|
inf% |
| 2020-03-31 |
$-0.10B |
|
inf% |
| 2019-12-31 |
$-0.11B |
|
inf% |
| 2019-09-30 |
$-0.10B |
|
inf% |
| 2019-06-30 |
$-0.10B |
|
inf% |
| 2019-03-31 |
$-0.08B |
|
inf% |
| 2018-12-31 |
$-0.08B |
|
inf% |
| 2018-09-30 |
$-0.05B |
|
inf% |
| 2018-06-30 |
$-0.04B |
|
inf% |
| 2018-03-31 |
$-0.05B |
|
inf% |
| 2017-12-31 |
$-0.05B |
|
inf% |
| 2017-09-30 |
$-0.06B |
|
inf% |
| 2017-06-30 |
$-0.06B |
|
inf% |
| 2017-03-31 |
$-0.05B |
|
inf% |
| 2016-12-31 |
$-0.06B |
|
inf% |
| 2016-09-30 |
$-0.06B |
|
inf% |
| 2016-06-30 |
$-0.05B |
|
inf% |
| 2016-03-31 |
$-0.05B |
|
inf% |
| 2015-12-31 |
$-0.03B |
|
inf% |
| 2015-06-30 |
$-0.01B |
|
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.115B |
$0.070B |
|
CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered in South San Francisco, California.
|
